Literature DB >> 31679119

Authors' Reply to "The Challenges of Studying Peripheral Vestibular Vertigo".

Arne W Scholtz1, Gerhard Weisshaar2.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 31679119     DOI： 10.1007/s40261-019-00872-8

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  6 in total

1.  Classification of vestibular symptoms: towards an international classification of vestibular disorders.

Authors:  Alexandre Bisdorff; Michael Von Brevern; Thomas Lempert; David E Newman-Toker
Journal:  J Vestib Res       Date:  2009       Impact factor: 2.435

2.  The Challenges of Studying Peripheral Vestibular Vertigo.

Authors:  James G Naples
Journal:  Clin Drug Investig       Date:  2020-01       Impact factor: 2.859

3.  Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.

Authors:  Arne-Wulf Scholtz; Raluca Steindl; Nicole Burchardi; Irene Bognar-Steinberg; Wolfgang Baumann
Journal:  Clin Drug Investig       Date:  2012-06-01       Impact factor: 2.859

4.  [Frequency of dizziness-related diagnoses and prescriptions in a general practice database].

Authors:  Carsten Kruschinski; Markus Kersting; Alf Breull; Michael M Kochen; Janka Koschack; Eva Hummers-Pradier
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2008

5.  Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial.

Authors:  Arne W Scholtz; Ales Hahn; Bohdana Stefflova; Daniela Medzhidieva; Sergey V Ryazantsev; Alexander Paschinin; Natalia Kunelskaya; Kai Schumacher; Gerhard Weisshaar
Journal:  Clin Drug Investig       Date:  2019-11       Impact factor: 2.859

6.  Cinnarizine and dimenhydrinate in the treatment of vertigo in medical practice.

Authors:  Arne-Wulf Scholtz; Justus Ilgner; Benjamin Loader; Bernd W Pritschow; Gerhard Weisshaar
Journal:  Wien Klin Wochenschr       Date:  2015-12-11       Impact factor: 1.704
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.